Kuros Biosciences announces start of of randomized controlled trial of MagnetOs in spinal fusion
News 12.06.2018 Study should further enhance competitive positioning of MagnetOs Kuros announced that the University Medical Center Utrecht (UMCU) in the Netherlands has obtained approval from its ethical committee to start an investigator-led multicenter study comparing MagnetOs with autologous bone in posterolateral spinal fusion. The study is entitled "A Randomized Controlled Trial of MagnetOs®...